angiotensin ii has been researched along with azilsartan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Brands, CM; Corral, E; de Roode, DF; Desmares-Koopmans, MJ; Migchielsen, MH; Oudhoff, KA; Weltman, R | 1 |
| Kusumoto, K | 1 |
| Arimoto, M; Hata, H; Osaka, S; Sakino, H; Sezai, A; Shiono, M; Yaoita, H | 1 |
| Gao, Q; Jiang, T; Ou, Z; Shi, JQ; Tian, YY; Wu, L; Zhang, YD; Zhou, JS | 1 |
| Hayakawa, Y; Iwasa, M; Kanamori, H; Kawasaki, M; Komaki, H; Minatoguchi, S; Nishigaki, K; Okamoto, C; Yamada, Y | 1 |
| Idemoto, Y; Kitajima, K; Kuwano, T; Matsuo, Y; Miura, SI; Suematsu, Y | 1 |
| Cai, SA; Hou, N; Huang, Y; Li, LR; Liu, XW; Luo, CF; Pan, WB; Shi, YY; Yuan, WC; Zhan, HX; Zhao, GJ | 1 |
1 review(s) available for angiotensin ii and azilsartan
| Article | Year |
|---|---|
[In vitro and in vivo pharmacological profiles of a novel angiotensin type 1-receptor blocker, azilsartan].
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypertension; Insulin Resistance; Obesity; Oxadiazoles | 2012 |
1 trial(s) available for angiotensin ii and azilsartan
| Article | Year |
|---|---|
Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Blood Pressure; Cardiac Surgical Procedures; Drug Substitution; Essential Hypertension; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Oxadiazoles; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Remodeling | 2016 |
5 other study(ies) available for angiotensin ii and azilsartan
| Article | Year |
|---|---|
Assessment of the environmental fate and effects of azilsartan, a selective antagonist of angiotensin II type 1.
Topics: Adsorption; Angiotensin II; Animals; Bacteria; Benzimidazoles; Biodegradation, Environmental; Daphnia; Environmental Monitoring; Geologic Sediments; Microalgae; Octanols; Oxadiazoles; Risk Assessment; Sewage; Toxicity Tests; Water Pollutants, Chemical | 2012 |
Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson's disease.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Behavior, Animal; Benzimidazoles; Disease Models, Animal; Dopaminergic Neurons; Humans; Male; Oxadiazoles; Parkinson Disease; Rats; Receptor, Angiotensin, Type 1; Substantia Nigra | 2017 |
Azilsartan attenuates cardiac damage caused by high salt intake through the downregulation of the cardiac (pro)renin receptor and its downstream signals in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Blood Pressure; Down-Regulation; Heart; Hypertension; Myocardium; Oxadiazoles; Phosphorylation; Prorenin Receptor; Rats; Rats, Inbred SHR; Receptors, Cell Surface; Signal Transduction; Sodium Chloride, Dietary; Transforming Growth Factor beta1 | 2018 |
Changes in the function of angiotensin II type 1 receptor due to cholesterol depletion from cell membrane.
Topics: Angiotensin II; Animals; Benzimidazoles; Cell Membrane; Chlorocebus aethiops; Cholesterol; COS Cells; Cyclic AMP; HEK293 Cells; Humans; Inositol Phosphates; Myocytes, Cardiac; Myocytes, Smooth Muscle; Oxadiazoles; Rats; Receptor, Angiotensin, Type 1 | 2019 |
Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Cardiomegaly; Female; Heart Ventricles; Kelch-Like ECH-Associated Protein 1; Male; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxadiazoles; Oxidative Stress; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Up-Regulation | 2021 |